Solmaz Sahebjam
Impact in
Papers in
- Oncology 65
- Cancer Immunotherapy and Biomarkers 31
- Lung Cancer Research Studies 16
- HER2/EGFR in Cancer Research 7
- CAR-T cell therapy research 7
-
- Brain Metastases and Treatment 47
- Lung Cancer Treatments and Mutations 9
- Co-authors
- Michael Lim (13 shared papers)David A. Reardon (12 shared papers)John H. Sampson (11 shared papers)Antonio Omuro (11 shared papers)Joachim M. Baehring (12 shared papers)Ricardo Zwirtes (7 shared papers)John S. Mort (3 shared papers)Rama Khokha (2 shared papers)
- Journals
- Journal of Clinical Oncology (22 papers)Neuro-Oncology (18 papers)Journal of Neuro-Oncology (6 papers)Cancer Research (5 papers)Annals of Oncology (4 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Solmaz Sahebjam
99 papers receiving 3.5k citations
Solmaz Sahebjam's Hit Papers
Peers
Comparison fields: 5 of 112
- Genetics 1.7k
- Oncology 1.7k
- Immunology 786
- Cancer Research 559
- Pulmonary and Respiratory Medicine 1.1k
Countries citing papers authored by Solmaz Sahebjam
This map shows the geographic impact of Solmaz Sahebjam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Solmaz Sahebjam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Solmaz Sahebjam more than expected).
Fields of papers citing papers by Solmaz Sahebjam
This network shows the impact of papers produced by Solmaz Sahebjam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Solmaz Sahebjam. The network helps show where Solmaz Sahebjam may publish in the future.
Co-authors
The 25 scholars most cited alongside Solmaz Sahebjam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma Hit paper breakdown → | 2020 | 946 |
| 2 | Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143 Hit paper breakdown → | 2017 | 362 |
| 3 | 2017 | 153 | |
| 4 | 2020 | 144 | |
| 5 | 2001 | 135 | |
| 6 | 2007 | 116 | |
| 7 | 2016 | 107 | |
| 8 | 2006 | 106 | |
| 9 | 2017 | 99 | |
| 10 | 2011 | 74 | |
| 11 | 2013 | 70 | |
| 12 | 2021 | 67 | |
| 13 | 2008 | 58 | |
| 14 | 2005 | 56 | |
| 15 | 2013 | 56 | |
| 16 | 2016 | 55 | |
| 17 | 2020 | 52 | |
| 18 | 2019 | 49 | |
| 19 | 2015 | 47 | |
| 20 | 2002 | 44 |
About Solmaz Sahebjam
Solmaz Sahebjam is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 111 papers that have together received 3.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (48 papers), Brain Metastases and Treatment (47 papers), Cancer Immunotherapy and Biomarkers (31 papers), Lung Cancer Research Studies (16 papers), Lung Cancer Treatments and Mutations (9 papers), HER2/EGFR in Cancer Research (7 papers), CAR-T cell therapy research (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). The work is most often cited by research in Genetics (1.7k citations), Oncology (1.7k citations), Immunology (786 citations), Cancer Research (559 citations) and Pulmonary and Respiratory Medicine (1.1k citations). Solmaz Sahebjam has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Michael Lim, David A. Reardon, John H. Sampson, Antonio Omuro, Joachim M. Baehring, Ricardo Zwirtes, John S. Mort, Rama Khokha, Michael Carleton and Alba A. Brandes. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Journal of Neuro-Oncology, Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.